FDA and Biotech MIRM: FDA Approves ATEBRIOZ on November 3 The local catalyst feed records an FDA approval for Mirum's ATEBRIOZ and orphan drug designation for brelovitug on November 3. The entries concern separate drugs and indications. November 10, 2026 · 6 min read
